Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Baseline characteristics and the information about operation

From: Analysis of the effect of initial hemostasis resuscitation with recombinant human coagulation factor VII a on the treatment of postoperative hemorrhage in cardiac surgery

 

IHR group(n = 102)

non-IHR group (n = 50)

p-value

Age, years

61.5(51.0,68.3)

62(52.8,67.3)

0.83

Male, n(%)

40(39.2)

21(42.0)

0.74

Hypertension, n(%)

13(12.8)

7(14.0)

0.86

Diabetes mellitus, n(%)

21(20.6)

12(24.0)

0.63

Smoking, n(%)

32(31.4)

15(30.0)

0.86

Drinking, n(%)

21(20.6)

12(24.0)

0.63

Renal dysfunction, n(%)

9(9.0)

7(14.0)

0.35

Coagulation abnormalities, n(%)

22(21.6)

13(26.0)

0.54

Emergency, n(%)

14(13.7)

7(14.0)

0.96

Hb, g/L

136.5 ± 18.7

137.2 ± 16.5

0.82

Platelet, ×109/L

197.5(148.0, 241.5)

190(145.5, 225.5)

0.55

ALT, U/L

17(12.0, 23.0)

18.5(11.8, 24.0)

0.8

AST, U/L

18.5(16.0, 22.8)

19(15.0, 24.3)

0.73

Aortic surgery, n(%)

24(23.5)

18(36.0)

0.11

OPCABG, n(%)

16(15.7)

3(6.0)

0.09

CPB time, min

147(97.0, 204.5)

175.5(111.0, 257.0)

0.06

Arrest time, min

95(16.5, 129.5)

98(53.3, 133.0)

0.79